UBS Group’s Revelation Biosciences, Inc. Warrant REVBW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16 | Buy |
1,300
+1,028
| +378% | +$13 | ﹤0.01% | 8806 |
|
|
2025
Q1 | $3 | Sell |
272
-2,240
| -89% | -$25 | ﹤0.01% | 8832 |
|
|
2024
Q4 | $18 | Sell |
2,512
-156
| -6% | -$1 | ﹤0.01% | 8533 |
|
|
2024
Q3 | $40 | Sell |
2,668
-2,047
| -43% | -$31 | ﹤0.01% | 8037 |
|
|
2024
Q2 | $94 | Buy |
+4,715
| New | +$94 | ﹤0.01% | 8007 |
|
|
2023
Q4 | – | Sell |
-78,000
| Closed | -$1.33K | – | 8473 |
|
|
2023
Q3 | $1.33K | Buy |
+78,000
| New | +$1.33K | ﹤0.01% | 6838 |
|
|
2023
Q2 | – | Sell |
-6,089
| Closed | -$97 | – | 8305 |
|
|
2023
Q1 | $97 | Buy |
+6,089
| New | +$97 | ﹤0.01% | 8148 |
|
|
2022
Q4 | – | Sell |
-5,124
| Closed | – | – | 9756 |
|
|
2022
Q3 | $0 | Sell |
5,124
-13,631
| -73% | – | ﹤0.01% | 9609 |
|
|
2022
Q2 | $2K | Buy |
18,755
+12,336
| +192% | +$1.32K | ﹤0.01% | 8561 |
|
|
2022
Q1 | $1K | Sell |
6,419
-421
| -6% | -$66 | ﹤0.01% | 8849 |
|
|
2021
Q4 | $5K | Buy |
+6,840
| New | +$5K | ﹤0.01% | 8288 |
|
|
2021
Q3 | – | Sell |
-1,015
| Closed | -$1K | – | 8703 |
|
|
2021
Q2 | $1K | Sell |
1,015
-302
| -23% | -$298 | ﹤0.01% | 8066 |
|
|
2021
Q1 | $1K | Buy |
+1,317
| New | +$1K | ﹤0.01% | 7748 |
|